Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction

Cardiology Journal

Volumn 21, Issue 5, 2014, Pages 500-508

  Sawant, Abhishek C ^a   Adhikari, Prabhat ^a   Narra, Swapna R ^a   Srivatsa, Shantanu V ^a   Mills, Paul K ^b   Srivatsa, Sanjay S ^a  

^a Landstuhl Regional Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Neutrophil to lymphocyte ratio; Percutaneous coronary revascularization; Predictors of mortality; ST elevation myocardial infarction; Thrombolysis In Myocardial Infarction risk score

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; ELECTROLYTE; HEMOGLOBIN; TROPONIN I;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD CLOT LYSIS; BLOOD SAMPLING; BODY MASS; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; FEMALE; FOLLOW UP; GENDER; GLOBAL REGISTRY OF ACUTE CORONARY EVENT SCORE; GLOMERULUS FILTRATION RATE; HEART ARREST; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMMUNOASSAY; KAPLAN MEIER METHOD; KIDNEY FUNCTION TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MAYO CLINIC RISK SCORE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUTROPHIL LYMPHOCYTE RATIO; PREDICTIVE VALUE; RACE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING; ST SEGMENT ELEVATION; BLOOD; CYTOLOGY; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; LYMPHOCYTE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUTROPHIL; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TRENDS; UNITED STATES;

AGED; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 84904606652     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.a2013.0148     Document Type: Article

References (30)

1. Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L. Circulating le­vels of proinflammatory cytokines and neutrophil-platelet aggre­gates in patients with coronary artery disease. Am J Cardiol, 2005; 95: 452–456.
2. Nessler J, Nessler B, Golebiowska-Wiatrak R et al. Serum bio­markers and clinical outcomes in heart failure patients treated de novo with carvedilol. Cardiol J, 2013; 20: 144–151.
3. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol, 2008; 102: 653–657.
4. Ates AH, Canpolat U, Yorgun H et al. Total white blood cell count is associated with the presence, severity and extent of coronary atherosclerosis detected by dual-source multislice computed to­mographic coronary angiography. Cardiol J, 2011; 18: 371–377.
5. Mazzone A, De Servi S, Ricevuti G et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coro­nary artery disease. Circulation, 1993; 88: 358–363.
6. Ishikawa M, Vowinkel T, Stokes KY et al. CD40/CD40 ligand sig­naling in mouse cerebral microvasculature after focal ischemia//reperfusion. Circulation, 2005; 111: 1690–1696.
7. Huang Y, Rabb H, Womer KL. Ischemia-reperfusion and imme­diate T cell responses. Cell Immunol, 2007; 248: 4–11.
8. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Car­diology Committee for the redefinition of myocardial infarction. Eur Heart J, 2000; 21: 1502–1513.
9. Thygesen K, Alpert JS, White HD, Joint ESCAAHAWHFTFftRo­MI. Universal definition of myocardial infarction. Eur Heart J, 2007; 28: 2525–2538.
10. Morrow DA, Antman EM, Charlesworth A et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intrave­nous nPA for treatment of infarcting myocardium early II trial substudy. Circulation, 2000; 102: 2031–2037.
11. Gibson CM, Cannon CP, Daley WL et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circu­lation, 1996; 93: 879–888.
12. Granger C.B GRJ, Dabbous O, et al. Predictors of Hospital Morta­lity in the Global Registry of Acute Coronary Events. Arch Intern Med, 2003; 163: 2345–2353.
13. Singh M, Gersh BJ, Li S et al. Mayo Clinic Risk Score for per­cutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery. Circulation, 2008; 117: 356–362.
14. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary in­tervention. Am J Cardiol, 2006; 97: 993–996.
15. Anderson JL, Ronnow BS, Horne BD et al. Usefulness of a com­plete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease. Am J Cardiol, 2007; 99: 169–174.
16. Nunez J, Nunez E, Bodi V et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST seg­ment elevation myocardial infarction. Am J Cardiol, 2008; 101: 747–752.
17. Manten A, de Winter RJ, Minnema MC et al. Procoagulant and proinflammatory activity in acute coronary syndromes. Cardio­vasc Res, 1998; 40: 389–395.
18. Lucchesi BR, Werns SW, Fantone JC. The role of the neutrophil and free radicals in ischemic myocardial injury. J Mol Cell Car­diol, 1989; 21: 1241–1251.
19. Rasouli M, Nesarhosseini V, Kiasari AM et al. The multiplicative interactions of leukocyte counts with some other risk factors enhance the prognostic value for coronary artery disease. Cardiol J, 2011; 18: 246–253.
20. Onsrud M, Thorsby E. Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on na­tural killer cell activity. Scand J Immunol, 1981; 13: 573–579.
21. Ergelen M, Uyarel H, Altay S et al. Predictive Value of Eleva­ted Neutrophil to Lymphocyte Ratio in Patients Undergoing Primary Angioplasty for ST-Segment Elevation Myocar­dial Infarction. Clin Appl Thromb Hemost 2013; Jan 11, doi: 10.1177/1076029612473516 [E-pub ahead of print].
22. Chia S, Nagurney JT, Brown DF et al. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST--elevation myocardial infarction. Am J Cardiol, 2009; 103: 333–337.
23. de la Camara AG, Guerravales JM, Tapia PM et al. Role of biolo­gical and non biological factors in congestive heart failure mor­tality: PREDICE-SCORE: A clinical prediction rule. Cardiol J, 2012; 19: 578–585.
24. Vaduganathan MAA, Greene SJ, Mentz RJ et al; EVEREST trial investigators. Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail, 2012; 5: 750–758.
25. D’Ascenzo F, Biondi-Zoccai G, Moretti C et al. TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: A meta­-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials, 2012; 33: 507–514.
26. Brkovic V, Dobric M, Beleslin B et al. Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Int J Cardiovasc Imaging, 2013; 29: 1215–1228.
27. Arbel YFA, Halkin A, Birati EY et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atheroscle­rosis, 2012; 225: 456–460.
28. Arruda-Olson AM, Reeder GS, Bell MR, Weston SA, Roger VL. Neutrophilia predicts death and heart failure after myocardial in­farction: A community-based study. Circ Cardiovasc Qual Outco­mes, 2009; 2: 656–662.
29. Amin ST, Morrow DA, Braunwald E et al. Dynamic TIMI risk score for STEMI. J Am Heart Assoc 2013; Jan 29, doi: 10.1161/JAHA.112.003269 [E-pub ahead of print].
30. Chang WC, Kaul P, Fu Y et al. Forecasting mortality: Dynamic assessment of risk in ST-segment elevation acute myocardial infarction. Eur Heart J, 2006; 27: 419–426.